STAT+: What can’t GLP-1s do? Study maps benefits while warning of uncommon risks
Image Credit: STAT News

STAT+: What can’t GLP-1s do? Study maps benefits while warning of uncommon risks

Watchdoq January 20, 2025
GLP-1 drugs like Ozempic have swept the world as effective therapies for far more than their original target of diabetes. Widely prescribed and wildly popular, particularly for the unprecedented weight…

Read Full Article